Bansel Stefan (Stephane Bancel)

Bansel Stefan (Stephane Bancel)

Biography

2022: Transferring your fortune to charity

At the end of May 2022, Stefan Bansel announced that he plans to donate most of his family fortune, focusing his charity on issues such as health and global food security. According to to data Bloomberg Billionaire's Index, the value of the CEO Moderna is estimated at $4.5 billion.

Stefan Bansel stated that it is reasonable to believe that the world is approaching the final stage of the coronavirus pandemic. According to him, he plans to realize part of his options for Moderna shares by the spring of 2023 and sell the shares by donating the proceeds.

According to Bloomberg, Bansel owns a 1.36% stake in Moderna, reducing his stake by about one sixth since the end of the first quarter of 2021. Shares of the manufacturer of vaccines for coronavirus infection (COVID-19) soared to a high of almost $500 per share in August 2021, and then lost in price amid fears that vaccine orders would not fall short of growth. From the fall of 2021 to the spring of 2022, the entire biotechnology sector also decreased.

The head of Moderna said that he was giving his fortune to charity. He has about $4.5 billion

{{quote 'There is a probability of 80% that as the omicron strain or SARS-CoV-2 as a whole spreads and mutations, we will see less and less virulent viruses. The remaining 20% is a scenario in which the following COVID-19 subspecies may be more dangerous. Based on this, I made such a decision, due to the fact that in the eternal pursuit of a beautiful life, some people do not have time to simply live, "said Moderna CEO Stefan Bancel. }} Stefan Bansel said he is also interested in more active philanthropic activities related to climate change. He invested in climate companies, in particular, in the company engaged in the development of nuclear fusion energy Commonwealth Fusion Systems. Bansel added that his teenage daughter convinced him to become a vegetarian, pointing to the climatic consequences of eating meat.^[1]

2021: Top billionaire rating thanks to COVID-19 vaccine sales

At the end of May 2021, it became known that thanks to sales of vaccines against COVID-19, at least nine pharmaceutical executives became billionaires. The profits of companies were reflected in the growth in the value of their shares, and this pleasantly affected the well-being of their owners.

The list of new billionaires is headed by Moderna CEO (MRNA) Stéphane Bancel and CEO BioNTech (BNTX), which produces a new vaccine along with Pfizer (PFE), Ugur Sahin. The fortune of both CEOs is about $4 billion.

Chinese senior executives CanSino Biologics and Moderna's first investors also became billionaires as company stocks soared to heaven. The value of Moderna shares has increased by more than 700% since February 2020, while the price of BioNTech shares has increased by 600%. Shares of CanSino Biologics rose about 440% over the same period. COVID-19 The company's one-dose vaccine was approved for use China in February 2021.

Activists said that such wealth creation emphasized the sharp inequality that arose as a result of the pandemic. According to campaigners, the fortune of nine new billionaires in the amount of $19.3 billion, and this amount is enough to fully vaccinate about 780 million people in low-income countries.

These billionaires are the human face of the huge profits that many pharmaceutical corporations receive because of the monopoly on these vaccines, said Oxfam health policy manager Anne Marriott. - The development of these vaccines was financed by public funds, and the finished product should be primarily a global public good, not an opportunity for private profit.

The release of the report coincided with the G20 Global Health Summit, at which world leaders are expected to discuss the waiver of intellectual property rights to vaccines.^[2]

Notes